RhumbLine Advisers’s Aesthetic Medical International Holdings AIH Stock Holding History

RhumbLine Advisers’s Portfolio AIH Stock Details AIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,270	Closed	-$696	–	4189
2024 Q4	$696	Sell	2,270 -17,845	-89%	-$5.47K	﹤0.01%	4088
2024 Q3	$8.01K	Hold	20,115	–	–	﹤0.01%	3917
2024 Q2	$8.97K	Hold	20,115	–	–	﹤0.01%	3997
2024 Q1	$6.23K	Hold	20,115	–	–	﹤0.01%	3946
2023 Q4	$13.9K	Hold	20,115	–	–	﹤0.01%	3819
2023 Q3	$14.4K	Buy	20,115 +8,120	+68%	+$6.94K	﹤0.01%	3825
2023 Q2	$12.4K	Buy	+11,995	New	+$12.7K	﹤0.01%	3901

RhumbLine Advisers's AIH Position: Q1 2025 in Review

RhumbLine Advisers sold out of Aesthetic Medical International Holdings (AIH) in Q1 2025, closing a stake of 2,270 shares — an estimated $696 sold.

RhumbLine Advisers first reported a position in AIH in Q2 2023 and held it in 7 quarters. The position peaked at $14.4K in Q3 2023. 0 funds tracked by Wall St. Rank hold AIH as of Q1 2025.

RhumbLine Advisers reported no remaining Aesthetic Medical International Holdings position as of Q1 2025 after selling out during the quarter.
RhumbLine Advisers sold 2,270 Aesthetic Medical International Holdings shares in Q1 2025, an estimated $696.
RhumbLine Advisers first reported a position in Aesthetic Medical International Holdings in Q2 2023 and held it in 7 quarters.
RhumbLine Advisers's Aesthetic Medical International Holdings position peaked at $14.4K in Q3 2023.
0 funds tracked by Wall St. Rank held Aesthetic Medical International Holdings as of Q1 2025.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.